Stocks and Investing Stocks and Investing
Wed, April 26, 2023
Tue, April 25, 2023
Mon, April 24, 2023

Tazeen Ahmad Downgraded (ADCT) to Sell and Decreased Target to $2 on, Apr 24th, 2023


Published on 2024-10-28 02:59:09 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Downgraded "ADC Therapeutics SA" (ADCT) to Sell and Decreased Target from $7 to $2 on, Apr 24th, 2023.

Tazeen has made no other calls on ADCT in the last 4 months.



There are 3 other peers that have a rating on ADCT. Out of the 3 peers that are also analyzing ADCT, 1 agrees with Tazeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $5 on, Tuesday, January 24th, 2023


These are the ratings of the 2 analyists that currently disagree with Tazeen


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $12 on, Monday, February 13th, 2023
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Wednesday, January 4th, 2023